Mendelson Eric A reported grant involving 10,000 derivative units of HEICO CORP at $0.00 for $0 on May 27, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Co-COB and Co-CEO
Co-COB and Co-CEO
Filed May 29, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
10,000Option (Right to purchase Common Stock)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
10,000Direct
Trade date
May 27, 2026Grant
Filed
May 29, 2026, 4:46 PM ET2-day reporting delay
Accession
0001031083-26-000002Code A · Transaction 93639
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

Returns since filing

Return windows need a valid ticker and filing date. Check the SEC source for missing filing facts.

Footnotes in full

F1: Represents shares gifted by the Reporting Person to trusts for the benefit of the Reporting Person's immediate family members and whose Trustee is the Reporting Person. F2: Represents shares owned by Mendelson International Corporation whose stock is owned solely by the Reporting Person and Victor Mendelson, the brother of the Reporting Person. F3: Represents shares owned by EAM Management Limited Partners, a partnership whose sole general partner is a corporation controlled by the Reporting Person. F4: Represents shares held for the benefit of the Reporting Person by the HEICO Corporation 401(k), based on a plan statement dated May 26, 2026. F5: Represents shares held for the Reporting Person by the HEICO Leadership Compensation Plan (409A Plan). F6: These options are exercisable at 20% per year over five years from the date of grant. F7: Represents the vesting of the first tranche (20%) of performance-based stock options originally granted on March 14, 2025. Vesting occurred upon certification by the Compensation Committee on May 27, 2026 that the applicable performance conditions for the first measurement interval were achieved.